The Company and its predecessors have owned and operated stereotactic radiosurgery centers, utilizing gamma knife technology since 1993. The Company currently holds an interest in and operates one gamma knife center on the premises of New York University Medical Center (“NYU”) in New York, New York. In January 2009, the Company, through its noncontrolling interest in Corona Gamma Knife, LLC, participated in the opening of a new center, the Southern California Regional Gamma Knife Center, at the San Antonio Regional Hospital (“SARH”) in Upland, California.
Company profile
Ticker
USNU
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
US NEUROSURGICAL INC
SEC CIK
Corporate docs
Subsidiaries
U.S. Neurosurgical, Inc. • USN Corona, Inc. • Elite Health Plan, Inc. • Elite Health Plan of Nevada, Inc. ...
IRS number
521842411
USNU stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
5 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
D/A
Exempt offering of security (amended)
6 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Jan 24
D
$2.00 mm in equity
10 Jan 24
8-K
Entry into a Material Definitive Agreement
28 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Departure of Directors or Certain Officers
19 Apr 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 559.00 k | 559.00 k | 559.00 k | 559.00 k | 559.00 k | 559.00 k |
Cash burn (monthly) | 72.33 k | 7.67 k | 50.33 k | 13.33 k | 42.67 k | 70.25 k |
Cash used (since last report) | 481.75 k | 51.06 k | 335.23 k | 88.80 k | 284.17 k | 467.88 k |
Cash remaining | 77.25 k | 507.94 k | 223.77 k | 470.20 k | 274.83 k | 91.12 k |
Runway (months of cash) | 1.1 | 66.3 | 4.4 | 35.3 | 6.4 | 1.3 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|